New twist to fluorescence-based microscopy lets scientists see up-close how Aβ aggregates in living cells.
A candidate reference method for measuring Aβ42 in cerebrospinal fluid brings researchers closer to standardization.
Playing nursemaid, TGF-β helps new neurons in the brain survive, develop, and migrate.
In award-winning documentary, son traces his mother’s progression into Alzheimer’s disease.
Combination Drug Trials: Time to Open a New Front in AD? Combination Trials: FDA Puts Flesh on Bones of Draft Guidance Combination Trials: Companies Can Play Well in One Sandbox Building a Roadmap for Shared Combination Drug Trials ACT-AD FDA/AD Allies ...
Meeting Explores Regulatory Requirements for Parkinson's MCI Michael J. Fox Foundation Conference ...
The proportion of seniors with dementia in England appears to be on the decline, new research suggests.
Brain atrophy plagues more than just people with neurodegenerative disorders...
An ultra-high-resolution 3D map of the human brain promises to help scientists studying neuroanatomy, neurosurgery, neurodegenerative disease, and more.
Similar to Alzheimer's disease, PD dementia begins with subtle deficits in cognition that progress to symptoms recognizable as mild cognitive impairment.
Epilepsy’s ties with Alzheimer’s disease occur earlier than previously thought.
G8 leaders set 2025 as their goal to find better treatment for Alzheimer's and vowed to coordinate research and care strategies.
The April issue of Health Affairs is dedicated to Alzheimer’s. Authors gathered in Washington, D.C., to articulate how world policy could take shape.
Exome sequencing identifies a new Alzheimer’s risk gene—phospholipase D3.
Researchers at BACE meeting explore how trafficking and degradation of the protease relate to amyloid pathology in AD.